CD37 Inhibitors
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a steroidal metabolite of fungi that acts as a potent and irreversible inhibitor of phosphoinositide 3-kinases (PI3K), which can influence signaling cascades that may be modulated by CD37. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a synthetic molecule functioning as a PI3K inhibitor, impacting various cellular processes that could be downstream of CD37 activity. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a synthetic compound designed as a tyrosine kinase inhibitor, affecting signal transduction pathways that might intersect with CD37's regulatory networks. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
Ibrutinib is a small molecule that inhibits Bruton's tyrosine kinase (BTK), potentially affecting B cell activity and signaling involving CD37. | ||||||
CAL-101 | 870281-82-6 | sc-364453 | 10 mg | $193.00 | 4 | |
Idelalisib is a selective PI3K inhibitor, targeting specifically the delta isoform, which is implicated in the activity of B cells where CD37 is present. | ||||||
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $118.00 $337.00 $520.00 $832.00 $1632.00 | 10 | |
Venetoclax is a BCL-2 inhibitor, which indirectly influences survival pathways in B cells expressing CD37. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Palbociclib is an inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6), which could indirectly affect cell cycle progression in cells interacting with CD37. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key kinase in regulating cell growth and proliferation, potentially intersecting with CD37 signaling. | ||||||
MLN8237 | 1028486-01-2 | sc-394162 | 5 mg | $220.00 | ||
Alisertib is an Aurora kinase A inhibitor, which can influence cell cycle and proliferation, affecting the cellular context of CD37. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor, affecting protein degradation pathways that might be connected to CD37's function. | ||||||